当前位置: X-MOL 学术Clin. Exp. Allergy › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
An Anti‐Siglec‐8 Antibody Depletes Sputum Eosinophils from Asthmatic Subjects and Inhibits Lung Mast Cells
Clinical & Experimental Allergy ( IF 6.1 ) Pub Date : 2020-07-08 , DOI: 10.1111/cea.13681
Sheena C Kerr 1 , Jeanmarie R Gonzalez 2, 3 , Julia Schanin 4 , Michael C Peters 1 , Bart N Lambrecht 5 , Emily C Brock 4 , Annabelle Charbit 1 , K M Ansel 2, 3 , Bradford A Youngblood 4 , John V Fahy 1, 3
Affiliation  

Sialic acid‐binding immunoglobulin‐like lectin (Siglec)‐8 is expressed on mast cells and eosinophils, but information about Siglec‐8 expression and function in the lung is limited. A humanized antibody, AK002, targeting Siglec‐8 is undergoing development for treatment of diseases associated with mast cell and eosinophil‐driven inflammation.

中文翻译:

一种抗 Siglec-8 抗体消耗哮喘患者的痰嗜酸性粒细胞并抑制肺肥大细胞

唾液酸结合免疫球蛋白样凝集素 (Siglec)-8 在肥大细胞和嗜酸性粒细胞上表达,但关于 Siglec-8 在肺中表达和功能的信息有限。一种靶向 Siglec-8 的人源化抗体 AK002 正在开发用于治疗与肥大细胞和嗜酸性粒细胞驱动的炎症相关的疾病。
更新日期:2020-07-08
down
wechat
bug